Experimental evidence also suggests that Galectin-1 expressed on various tumor-cell types including hepatocellular carcinoma, melanoma, ovarian, and prostate cancer cells mediates tumor-cell adhesion to the extracellular matrix (133, 134). Here, LGALS1 is linked to melanoma.